PubMed Health⌕ Search

Biomedical subjects

M Sancho Mestre

Publications and source records attributed to M Sancho Mestre.

6 recordsLinked to original sources

[Hibernoma: a rare case of cervical mass].

The hibernoma is an uncommon benign tumor thought to arise from the vestiges of the fetal brown fat. The term hibernoma is derived from the microscopic similarity of this tumor to the glandular brown adipose tissue occurring in the organs of hibernation of certain animal species. There are reported about 100 hibernomas in the literature world wide and only a small number of them are in the neck. We report the case of a 33 years old male with a 20 months history of a painless mass in his right neck.

Adult↗

[Bilateral aneurysm of the internal carotid artery and thrombosis of the jugular vein. Case report].

Extracranial carotid artery aneurysms is a very odd pathology which first sign usually is a neck mass. At present the arteriosclerosis is considered its main source and surgery is promoted as its regular treatment, but each case must be managed according the distinct peculiarities showed. This paper reports the clinic and radiological features of a woman diagnosed of bilateral carotid aneurysm with the addition of a thrombosis check afterwards of the left jugular vein. Because of the rarity of this case think justified the record. A bibliographical perusal of this singular entity accompanies the article.

Aged↗

[Neck phlebectasia].

Neck phlebectasia is an infrequent anomaly of the venous system, possibly a congenital condition, becoming apparent as a neck mass triggered by the Valsalva maneuver or any other exploratory afford with closed nose. Commonly localized in the jugular venous system, although it can turn-up, the ectasia, to other cervicofacial veins. In this paper are reported 3 neck phlebectasis including one of them affecting the anterior facial vein, occurrence exceedingly uncommon, of which case we don't know even a single reference in the literature. We make a perusal of the subject's bibliography and also discuss the clinic, diagnostic and therapeutical most important features of this entity.

Adult↗

[Twenty years of retrospective study of malignant paranasal sinus tumors].

Carcinomas of the nasal cavity and paranasal sinuses represent 3% of tumors of the head and neck. Their histology and location vary widely. We reviewed the case histories of patients with malignant tumors of the nasal sinuses seen by us between 1975 and 1996, a total of 37 suitable cases. The site of origin of the tumor was the maxillary sinus in 16 cases, ethmoid sinus in 15, nasal septum in 3, nasal roof in 2, and nasal floor in 1 case. Fifty percent of the tumors were squamous cell carcinomas, 11% undifferentiated carcinomas, 13% non-squamous carcinomas, 5% melanomas, 5% olfactory neuroblastomas, 3% chondrosarcomas and 8% non-Hodgkin lymphomas. When diagnosed, one patient had carcinoma in situ, 3 stage I, 5 stage II, 12 stage III and 16 stage i.v. The cumulative survival was 63% after 3 years and 47% after 5 years.

Adult↗

[Solitary plasmacytoma of the head and neck. Report of 3 cases and review of the literature].

Solitary plasmocytoma is a rare plasmactic cell tumor occurring in the head and neck. These constitute, less than 1% of all head and neck malignancies. On initial presentation they must be differentiated from multiple myeloma. This may prove to be difficult because a varying percentage may be associated at a later date with the development of multiple myeloma. We describe three cases of plasmocytomas, one occurred in the larynx, in the cavity nasal and other in the skull base. The clinical characteristics, diagnosis criteria and therapeutic problems (radiation, surgery or a combination of booth) are discussed and reviewed in the literature.

Adult↗

[Protocol for sino-nasal tumors in our service].

Tumors of the nasal fossa and paranasal region are uncommon and have non-specific initial clinical features. This complicates the diagnosis and delays treatment. We reviewed all our cases of nasal sinus tumors (84 benign, 50 malignant and 15 moderately malignant) and the relevant literature. This data was use to develop a protocol for classifying the symptoms, clinical and radiological features, coded diagnosis, and the most suitable treatment and follow-up.

Clinical Protocols↗